Literature DB >> 10413524

Stoichiometry of the interaction between the major histocompatibility complex-related Fc receptor and its Fc ligand.

L M Sánchez1, D M Penny, P J Bjorkman.   

Abstract

The neonatal Fc receptor (FcRn) transports immunoglobulin G (IgG) across epithelia, providing passive immunity and protecting serum IgG from degradation. For both functions, FcRn binds to IgG at the acidic pH of intracellular vesicles (pH </= 6.5) and releases IgG at the basic pH of the bloodstream (pH approximately 7.4). Crystallographic studies show that rat FcRn can interact with the Fc portion of IgG in a repeating array in which FcRn dimers are bridged by Fc fragments to create an "oligomeric ribbon" with a 2n:n stoichiometry. The stoichiometry of the interaction between soluble FcRn and Fc has been reported as either 2:1 for rat FcRn [Huber et al. (1993) J. Mol. Biol. 230, 1077-1083] or 1:1 for mouse FcRn [Popov et al. (1996) Mol. Immunol. 33, 521-530]. To ascertain the reasons for this difference, we analyzed complexes formed in solution between soluble rat or mouse FcRn and Fc. Using a gel-filtration assay under nonequilibrium conditions, we find that both forms of FcRn produce 2:1 receptor-ligand complexes, but that alterations of the carbohydrate moieties on mouse FcRn can result in an apparent stoichiometry of 1:1. However, under equilibrium conditions, all forms of FcRn make complexes with a 2:1 stoichiometry. We conclude that rat and mouse FcRn share the same general ligand binding properties but that small differences in affinities can produce apparent differences under nonequilibrium conditions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10413524     DOI: 10.1021/bi9907330

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

Review 1.  Transcytosis and catabolism of antibody.

Authors:  Victor Ghetie; E Sally Ward
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  A high throughput capillary electrophoresis method to obtain pharmacokinetics and quality attributes of a therapeutic molecule in circulation.

Authors:  Reema Piparia; David Ouellette; W Blaine Stine; Christine Grinnell; Edit Tarcsa; Czeslaw Radziejewski; Ivan Correia
Journal:  MAbs       Date:  2012-07-01       Impact factor: 5.857

3.  Analytical FcRn affinity chromatography for functional characterization of monoclonal antibodies.

Authors:  Tilman Schlothauer; Petra Rueger; Jan Olaf Stracke; Hubert Hertenberger; Felix Fingas; Lothar Kling; Thomas Emrich; Georg Drabner; Stefan Seeber; Johannes Auer; Stefan Koch; Apollon Papadimitriou
Journal:  MAbs       Date:  2013-05-29       Impact factor: 5.857

Review 4.  FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin.

Authors:  Michal Pyzik; Timo Rath; Wayne I Lencer; Kristi Baker; Richard S Blumberg
Journal:  J Immunol       Date:  2015-05-15       Impact factor: 5.422

Review 5.  Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn.

Authors:  E Sally Ward; Raimund J Ober
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

6.  Anti-PolyQ Antibodies Recognize a Short PolyQ Stretch in Both Normal and Mutant Huntingtin Exon 1.

Authors:  Gwen E Owens; Danielle M New; Anthony P West; Pamela J Bjorkman
Journal:  J Mol Biol       Date:  2015-06-03       Impact factor: 5.469

Review 7.  Proteolysis and Oxidation of Therapeutic Proteins After Intradermal or Subcutaneous Administration.

Authors:  Ninad Varkhede; Rupesh Bommana; Christian Schöneich; M Laird Forrest
Journal:  J Pharm Sci       Date:  2019-08-10       Impact factor: 3.534

8.  Design and characterization of novel dual Fc antibody with enhanced avidity for Fc receptors.

Authors:  Dennis R Goulet; Adam Zwolak; James A Williams; Mark L Chiu; William M Atkins
Journal:  Proteins       Date:  2019-11-20

9.  Impact of SPR biosensor assay configuration on antibody: Neonatal Fc receptor binding data.

Authors:  Xiangdan Wang; Patrick McKay; Liliana T Yee; George Dutina; Philip E Hass; Ihsan Nijem; David Allison; Kyra J Cowan; Kevin Lin; Valerie Quarmby; Jihong Yang
Journal:  MAbs       Date:  2016-12-21       Impact factor: 5.857

10.  Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn.

Authors:  Adam R Mezo; Kevin A McDonnell; Cristina A Tan Hehir; Susan C Low; Vito J Palombella; James M Stattel; George D Kamphaus; Cara Fraley; Yixia Zhang; Jennifer A Dumont; Alan J Bitonti
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.